Clinical Research Directory
Browse clinical research sites, groups, and studies.
68Ga-PSMA PET in the Renal Cell Carcinoma
Sponsor: Xijing Hospital
Summary
The primary research purpose is to evaluate the diagnostic efficacy of 68Ga-PSMA PET in metastatic lesions of locally advanced and advanced renal cell carcinoma, and to compare with that of enhanced CT. The second purpose is to evaluate whether 68Ga-PSMA PET can change the treatment decision of patients with locally advanced and advanced renal cell carcinoma
Official title: A Prospective, Multicenter Study of Diagnostic Efficiency of 68Ga-PSMA PET in the Patients With Locally Advanced and Advanced Renal Cell Carcinoma
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2021-06-01
Completion Date
2027-12-01
Last Updated
2026-03-11
Healthy Volunteers
No
Conditions
Interventions
PSMA PET
PSMA PET may have influence on the clinical decision-making of the patients with renal cancer
Locations (9)
The First Hospital of Lanzhou University
Lanzhou, Gansu, China
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China
Qinghai University Affiliated Hospital
Xining, Qinghai, China
Xijing Hospital
Xi'an, Shaan'xi, China
Weinan Central Hospital
Weinan, Shaanxi, China
Shaanxi Provincial People's Hospital
Xi'an, Shaanxi, China
Xijing 986 Hospital
Xi'an, Shaanxi, China
The Second Affiliated Hospital of Shaanxi University of Chinese Medicine
Xianyang, Shaanxi, China
Affiliated Hospital of Yan'an University
Yan’an, Shaanxi, China